AR065602A1 - Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y uso - Google Patents
Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y usoInfo
- Publication number
- AR065602A1 AR065602A1 ARP080100908A ARP080100908A AR065602A1 AR 065602 A1 AR065602 A1 AR 065602A1 AR P080100908 A ARP080100908 A AR P080100908A AR P080100908 A ARP080100908 A AR P080100908A AR 065602 A1 AR065602 A1 AR 065602A1
- Authority
- AR
- Argentina
- Prior art keywords
- dihydro
- amino
- heptanoic
- dioxide
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
En la presente solicitud se revelan polimorfos de S,S-dioxido del ácido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-iI)amino]heptanoico. También se describen aquí composiciones farmacéuticas que comprenden uno o varios polimorfos deS,S-dioxido ácido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]heptanoico, métodos para su preparacion, y métodos de tratamiento relacionados. Reivindicacion 2: La Forma 1 de S,S-dioxido del ácido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]heptanoico de la reivindicacion 1, donde dicha Forma 1 exhibe un difractograma de rayos X en polvo que comprende un pico a 2-theta aproximadamente 5,89 grados. Reivindicacion 11: La Forma 2 deS,S-dioxido del ácido 7-[(3-cloro-6,11-dihidro-6- metildibenzo[c,f][1,2]tiazepin-11-il)amino]heptanoico de la reivindicacion 10, donde dicha Forma 2 exhibe un difractograma de rayos X en polvo que comprende un pico a 2-theta aproximadamente 8,52grados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89294707P | 2007-03-05 | 2007-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR065602A1 true AR065602A1 (es) | 2009-06-17 |
Family
ID=39738742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080100908A AR065602A1 (es) | 2007-03-05 | 2008-03-05 | Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y uso |
Country Status (11)
Country | Link |
---|---|
US (1) | US8367656B2 (es) |
EP (1) | EP2137157A4 (es) |
JP (1) | JP2010520298A (es) |
AR (1) | AR065602A1 (es) |
CA (1) | CA2679936C (es) |
CL (1) | CL2008000653A1 (es) |
JO (1) | JO3046B1 (es) |
PE (2) | PE20090534A1 (es) |
TW (1) | TWI436988B (es) |
UY (1) | UY30952A1 (es) |
WO (1) | WO2008109577A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198268B2 (en) * | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
US10624902B1 (en) | 2017-08-08 | 2020-04-21 | James Peter Morrissette | Dietary supplement |
CN111448195A (zh) * | 2017-09-27 | 2020-07-24 | 费多拉制药公司 | 二氮杂二环辛烷衍生物的晶型及其生产方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3758528A (en) | 1970-03-13 | 1973-09-11 | Science Union & Cie | Tricyclic compounds |
JPS535661B2 (es) * | 1972-03-07 | 1978-03-01 | ||
CA995213A (fr) | 1972-03-16 | 1976-08-17 | Charles Malen | Procede de preparation de derives tricycliques |
FR2594827B1 (fr) * | 1986-02-21 | 1988-05-20 | Adir | Nouveau derive tricyclique denomme acide ((chloro-3 methyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazepine (1,2) yl-11 amino)-5 pentazoique, son procede de preparation et les compositions pharmaceutiques qui le contiennent |
FR2716623B1 (fr) * | 1994-02-25 | 1996-08-23 | Adir | Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs. |
GB9624615D0 (en) * | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Chrystallisation process |
DE60001054T2 (de) * | 1999-02-04 | 2003-07-24 | Wyeth, Madison | Trizyclische pyridin n-oxide vasopressin agonisten |
DK1409101T3 (da) * | 2001-05-05 | 2006-07-31 | Accentus Plc | Dannelse af små krystaller |
US6683072B1 (en) * | 2003-02-04 | 2004-01-27 | Vela Pharmaceuticals, Inc. | Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia |
-
2008
- 2008-03-04 EP EP08731316A patent/EP2137157A4/en not_active Ceased
- 2008-03-04 US US12/041,747 patent/US8367656B2/en active Active
- 2008-03-04 CA CA2679936A patent/CA2679936C/en active Active
- 2008-03-04 TW TW097107564A patent/TWI436988B/zh not_active IP Right Cessation
- 2008-03-04 JP JP2009552831A patent/JP2010520298A/ja active Pending
- 2008-03-04 WO PCT/US2008/055746 patent/WO2008109577A1/en active Application Filing
- 2008-03-05 UY UY30952A patent/UY30952A1/es unknown
- 2008-03-05 PE PE2008000432A patent/PE20090534A1/es not_active Application Discontinuation
- 2008-03-05 AR ARP080100908A patent/AR065602A1/es unknown
- 2008-03-05 CL CL200800653A patent/CL2008000653A1/es unknown
- 2008-03-05 JO JOP/2008/0099A patent/JO3046B1/ar active
- 2008-03-05 PE PE2012000103A patent/PE20120574A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2008000653A1 (es) | 2008-10-24 |
EP2137157A1 (en) | 2009-12-30 |
UY30952A1 (es) | 2008-09-30 |
PE20090534A1 (es) | 2009-05-03 |
US8367656B2 (en) | 2013-02-05 |
EP2137157A4 (en) | 2010-12-15 |
CA2679936C (en) | 2017-07-11 |
PE20120574A1 (es) | 2012-05-23 |
JO3046B1 (ar) | 2016-09-05 |
TW200846331A (en) | 2008-12-01 |
US20080221081A1 (en) | 2008-09-11 |
CA2679936A1 (en) | 2008-09-12 |
JP2010520298A (ja) | 2010-06-10 |
TWI436988B (zh) | 2014-05-11 |
WO2008109577A1 (en) | 2008-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
NZ596579A (en) | Bace inhibitors | |
CL2012000163A1 (es) | Compuestos derivados de quinazolina o pirido[2,3-d]pirimidina, inhibidores de la autofagia; composicion farmaceutica; y su uso para el tratamiento del cancer, pancreatitis, neurodegeneracion, entre otras. | |
ECSP099044A (es) | Compuestos de pirimido fusionados | |
CL2007001283A1 (es) | Compuestos derivados de pirazinona | |
CL2007000806A1 (es) | Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer. | |
MX2011007424A (es) | Derivados de sulfonamida. | |
GEP201606555B (en) | Compounds and compositions for modulating egfr activity | |
TW200801003A (en) | Novel compounds | |
AR065247A1 (es) | Sal de napadisilato y/o heminapadisilato de 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino]-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona,composiciones farmaceuticas que las contienen y usos en el tratamiento del asma y otras enfermedades pulmonares. | |
GEP20156366B (en) | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use | |
BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
MX2011011661A (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750. | |
TW200745040A (en) | Quinoline derivatives | |
BR112012016797A2 (pt) | intensificador dinâmico de baixo utilizando compressor com equalizador incorporado | |
UA103319C2 (en) | Thiazole- and oxazole-benzene sulfonamide compounds | |
AR058098A1 (es) | Derivados de acidos dicarboxilicos y su uso | |
CL2007003765A1 (es) | Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias. | |
TW200716529A (en) | New compounds II | |
CL2008002689A1 (es) | Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia. | |
GEP201706656B (en) | 2-thiopyrimidinones | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
WO2007097981A3 (en) | Alpha carbolines and uses thereof | |
GEP20135959B (en) | Aryl piperazine and their usage as alpha2c antagonists | |
MX2012005225A (es) | Compuestos y composiciones de purina n-7 sustituida y pirazolopirimidina, y metodos de uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |